Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Impax Laboratories Inc (NASDAQ:IPXL)

22.80
Delayed Data
As of Sep 25
 -0.20 / -0.87%
Today’s Change
7.75
Today|||52-Week Range
27.29
+72.08%
Year-to-Date
Impax Shares Jump on Merger Buzz
Sep 21 / TheStreet.com - Paid Partner Content
 

Today’s Trading

Previous close23.00
Today’s open23.00
Day’s range22.70 - 23.40
Volume1,242,522
Average volume (3 months)1,659,375
Market cap$1.7B
Dividend yield--
Data as of 3:59pm ET, 09/25/2017

Growth & Valuation

Earnings growth (last year)-1,327.78%
Earnings growth (this year)-39.82%
Earnings growth (next 5 years)+6.21%
Revenue growth (last year)-4.19%
P/E ratioNM
Price/Sales1.14
Price/Book2.72

Competitors

 Today’s
change
Today’s
% change
LXRXLexicon Pharmaceutic...+0.18+1.45%
RGENRepligen Corp-0.54-1.23%
ARRYArray Biopharma Inc0.000.00%
EBSEmergent BioSolution...+0.21+0.55%
Data as of 3:59pm ET, 09/25/2017

Financials

Next reporting dateNovember 7, 2017
EPS forecast (this quarter)$0.20
Annual revenue (last year)$824.4M
Annual profit (last year)-$472.0M
Net profit margin-57.26%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President, Chief Executive Officer &
Director
Paul M. Bisaro
Senior Vice President-
Global Operations
Andrew Schaschl
Corporate headquarters
Hayward, California

Forecasts